(Q42804904)

7 November 2017

title

Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays (English)

1 reference

7 November 2017

Sadick MD

1

1 reference

7 November 2017

Intintoli A

2

1 reference

7 November 2017

Quarmby V

3

1 reference

7 November 2017

McCoy A

4

1 reference

7 November 2017

Canova-Davis E

5

1 reference

7 November 2017

Ling V

6

1 reference

7 November 2017

publication date

1 May 1999

1 reference

Journal of Pharmaceutical and Biomedical Analysis

7 November 2017

published in

1 reference

7 November 2017

volume

19

1 reference

7 November 2017

issue

6

1 reference

7 November 2017

page(s)

883-891

1 reference

7 November 2017

cites work

Protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

Signal transduction by receptors with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

The type 1 (EGFR-related) family of growth factor receptors and their ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

Primary structure and biological activity of a novel human neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

Ras proteins are essential and selective for the action of insulin-like growth factor 1 late in the G1 phase of the cell cycle in BALB/c murine fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

Constitutively expressed c-myb abrogates the requirement for insulinlike growth factor 1 in 3T3 fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

Multiple pathways are involved in protection of MCF-7 cells against death due to protein synthesis inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

Epidermal growth factor and insulin-like growth factor-1 preserve cell viability in the absence of protein synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

Overexpression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

Analysis of heregulin-induced ErbB2 phosphorylation with a high-throughput Kinase receptor activation enzyme-linked immunosorbant assay

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

Analysis of neurotrophin/receptor interactions with a gD-flag-modified quantitative kinase receptor activation (gD.KIRA) enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

The trk proto-oncogene encodes a receptor for nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2898%2900144-7

7 January 2021

10.1016/S0731-7085(98)00144-7

Identifiers

DOI

1 reference

7 November 2017

1 reference